Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Egorin

Showing results (111-120 of 159) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?M J Glantz, B F Cole, L Recht, et al.
Cancer Chemotherapy and Pharmacology|January 29, 1999
A pilot phase I trial of continuous hyperthermic peritoneal perfusion with high-dose carboplatin as primary treatment of patients with small-volume residual ovarian cancerM A Steller, M J Egorin, E L Trimble, et al.
Cancer|October 15, 1980
Cis-Dichlorodiammine platinum and adriamycin therapy for advanced gynecological and genitourinary neoplasmsS Ostrow, M J Egorin, D Hahn, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Plasma pharmacokinetics, bioavailability, and tissue distribution in CD2F1 mice of halomon, an antitumor halogenated monoterpene isolated from the red algae Portieria hornemanniiM J Egorin, D L Sentz, D M Rosen, et al.
Cancer Journal (Sudbury, Mass.)|October 19, 2000
Phase I and pharmacokinetic study of novobiocin in combination with VP-16 in patients with refractory malignanciesJ R Murren, S A DiStasio, A Lorico, et al.
Biochemical Pharmacology|May 30, 1998
Anthracycline antibiotic blockade of SV40 T antigen helicase actionN R Bachur, L Lun, P M Sun, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Phase I trial of chloroguinoxaline sulfonamide, with correlation of its pharmacokinetics and pharmacodynamicsB A Conley, S O'Hara, S Wu, et al.
Cancer Treatment Reports|January 1, 1981
High-dose cisplatin therapy using mannitol versus furosemide diuresis: comparative pharmacokinetics and toxicityS Ostrow, M J Egorin, D Hahn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2006
Peripheral blood mononuclear and tumor cell pharmacodynamics of the novel epothilone B analogue, ixabepiloneS Mani, H M McDaid, A Grossman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Phase I clinical trial of all-trans-retinoic acid with correlation of its pharmacokinetics and pharmacodynamicsB A Conley, M J Egorin, R Sridhara, et al.
Pageof 16

Showing results (111-120 of 159) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?M J Glantz, B F Cole, L Recht, et al.
Cancer Chemotherapy and Pharmacology|January 29, 1999
A pilot phase I trial of continuous hyperthermic peritoneal perfusion with high-dose carboplatin as primary treatment of patients with small-volume residual ovarian cancerM A Steller, M J Egorin, E L Trimble, et al.
Cancer|October 15, 1980
Cis-Dichlorodiammine platinum and adriamycin therapy for advanced gynecological and genitourinary neoplasmsS Ostrow, M J Egorin, D Hahn, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Plasma pharmacokinetics, bioavailability, and tissue distribution in CD2F1 mice of halomon, an antitumor halogenated monoterpene isolated from the red algae Portieria hornemanniiM J Egorin, D L Sentz, D M Rosen, et al.
Cancer Journal (Sudbury, Mass.)|October 19, 2000
Phase I and pharmacokinetic study of novobiocin in combination with VP-16 in patients with refractory malignanciesJ R Murren, S A DiStasio, A Lorico, et al.
Biochemical Pharmacology|May 30, 1998
Anthracycline antibiotic blockade of SV40 T antigen helicase actionN R Bachur, L Lun, P M Sun, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Phase I trial of chloroguinoxaline sulfonamide, with correlation of its pharmacokinetics and pharmacodynamicsB A Conley, S O'Hara, S Wu, et al.
Cancer Treatment Reports|January 1, 1981
High-dose cisplatin therapy using mannitol versus furosemide diuresis: comparative pharmacokinetics and toxicityS Ostrow, M J Egorin, D Hahn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2006
Peripheral blood mononuclear and tumor cell pharmacodynamics of the novel epothilone B analogue, ixabepiloneS Mani, H M McDaid, A Grossman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Phase I clinical trial of all-trans-retinoic acid with correlation of its pharmacokinetics and pharmacodynamicsB A Conley, M J Egorin, R Sridhara, et al.
Pageof 16